Application of Antiosteoporosis Therapy in Osteolysis
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorHenan Cancer Hospital
About this trial
To report the postoperative complications and limb function of patients with osteolysis after surgery for bone tumors of the extremities who received anti-osteoporosis therapy in Henan Cancer Hospital in the next 10 years.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
No age restriction, male or female.
A subtype of bone tumor (including benign, malignant, and metastatic cancer) was confirmed in the pathology department of the research institution.
Received excision of bone tumor in research institution.
Disqualifiers
None
Trial population
Patients receiving antiosteoporosis therapy for osteolysis after surgery for bone tumors in the extremities
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
Anti-osteoporosis therapy
Other interventionBone healing, limb function, and complications of postoperative osteolysis in patients with bone tumors of the extremities treated with anti-osteoporosis therapy.
Treatment groups
100 Participants
are divided into 2 treatment groupsGroup A: Intervention group1 intervention
Group B: Control group0 interventions
Trial outcomes
Primary outcomes
1
Complications
The incidence of complications after anti-osteoporosis treatment was collected and the severity of complications was evaluated according to CTCAE5.0.
Time frame
Collected from the beginning of treatment to 24 months after treatment.2
Limb function
Limb function was assessed using the Musculoskeletal Oncology Society (MSTS) scoring scale for seven items, namely movement, pain, stability, deformity, strength, functional activity, and emotional receptiveness. The highest possible score is 35, with 5 points allocated to each project.
Time frame
Collected from the beginning of treatment to 24 months after treatment.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: